KY-05009 is an ATP-Competitive TNIK Inhibitor with Anti-Tumor Activity
Multiple myelomas (MM) is a plasma cell malignancy that accounts for approximately 10% of all hematological malignancies. Many new drugs and therapies apply to this disease, but it remains an…
